| Literature DB >> 33312506 |
Ali Issakou Malam Tchole1,2, Zhen-Wei Li1, Jia-Te Wei1, Run-Ze Ye1,3, Wen-Jing Wang1, Wan-Yu Du1, Hai-Tao Wang1, Chao-Nan Yin1, Xiao-Kang Ji4, Fu-Zhong Xue4, Alassan Maman Bachir2, Lin Zhao1, Wu-Chun Cao1,3.
Abstract
BACKGROUND: The COVID-19 pandemic is challenging the public health response system worldwide, especially in poverty-stricken, war-torn, and least developed countries (LDCs).Entities:
Mesh:
Year: 2020 PMID: 33312506 PMCID: PMC7719275 DOI: 10.7189/jogh.10.020513
Source DB: PubMed Journal: J Glob Health ISSN: 2047-2978 Impact factor: 4.413
Demographic, epidemiologic, and clinical characteristics of COVID-19 cases in Niger*
| Characteristics | COVID-19 cases (n = 1093) |
|---|---|
| 19 March 2020 – 4 July 2020 | |
| 43 (28-57) | |
| Male | 741 (67.8%) |
| Female | 352 (32.2%) |
| Health care workers | 140 (12.8%) |
| Soldiers | 46 (4.2%) |
| Students | 107 (9.8%) |
| Housewives | 75 (6.9%) |
| Others | 537 (49.1%) |
| Unknown | 188 (17.2%) |
| 3 (1-7) | |
| 5 (2-9) | |
| 6 (3-10) | |
| Yes | 62 (5.7%) |
| No | 1031 (94.3%) |
| Treatment in a hospital | 663 (60.7%) |
| Treatment at home | 430 (39.3%) |
| Asymptomatic case | 462 (42.3%) |
| Symptomatic case: | 631 (57.7%) |
| Cough | 441 (69.9%) |
| Fever | 399 (63.2%) |
| Shortness of breath | 233 (36.9%) |
| Sore throat | 149 (23.6%) |
| Runny nose | 115 (18.2%) |
| Chest pain | 59 (9.4%) |
| Headache | 99 (15.7%) |
| Fatigue | 57 (9.0%) |
| Anosmia | 49 (7.8%) |
| Malaise | 14 (2.2%) |
| Diarrhea | 17 (2.7%) |
| Anorexia | 14 (2.2%) |
| Remained in hospital | 105 (9.6%) |
| Discharged | 899 (82.3%) |
| Died | 89 (8.1%) |
*Data are median (IQR), n (%), or n/N (%).
†11 (1.0%) cases with missing values have been deleted when calculating.
Figure 1Geographical distribution and spatial clustering of COVID-19 cases in Niger. Thematic map shows the commune-level attack rate of COVID-19 in Niger. Areas highlighted with red or pink edging represent most likely cluster area and secondary likely cluster area, respectively.
Figure 2Age and gender differences in incidence and fatality of COVID-19 in Niger. Panel A. The attack rate (AR) and case fatality rate (CFR). Panel B. AR of symptomatic cases (left) and asymptomatic cases (right). Panel C. CFR in Niamey (left) and other regions (right).
Figure 3Epidemic curve and estimated effective reproduction number (R) during the COVID-19 outbreak in relation to public health control measures in Niger. Panel A. Epidemic curve (symptom onset and report date) of cases. Panel B. Estimated R in relation to public health control measures. Values represent average R (central dark blue line) and associated 95% confidence interval (light blue shade), by date of symptom onset. The critical value of R = 1 is marked with a horizontal dot line, below which sustained transmission is impossible. Triangles at the bottom represent the moment of important public health control measures: (1) The practice of social distancing in Niamey (17 March 2020); (2) The Ministry of Public Health announced the first COVID-19 case in Niger, and the authorities developed the national COVID-19 Emergency Preparedness and Response Plan (19 March 2020); (3) Targeted control measures have been implemented in Niamey and throughout the country, such as closure of places of worship, health screenings and border control, banned on non-essential visits to remand centers, quarantine at home and establishment of temporary hospitals (20 March 2020); (4) The authorities declared the state health emergency (27 March 2020); (5) Travel ban and Curfew in Niamey (28 March 2020); (6) Lockdown of Niamey (29 March 2020); (7) Reopened places of worship (13 May 2020).
Disability-adjusted life years (DALYs) of COVID-19 in Niger
| Age Group | Males | Females | Total population | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0-4 | 30.25 | 0.02 | 30.27 | 0.01 | 99.93 | 3.63 | 0.00 | 0.00 | 0.00 | 0.00 | NA | 0.00 | 30.27 | 0.01 | 99.93 | 2.39 |
| 5-14 | 0.00 | 0.24 | 0.24 | 0.00 | 0.00 | 0.03 | 0.00 | 0.13 | 0.13 | 0.00 | 0.00 | 0.03 | 0.37 | 0.00 | 0.00 | 0.03 |
| 15-29 | 0.00 | 1.70 | 1.70 | 0.00 | 0.00 | 0.20 | 82.35 | 0.88 | 83.23 | 0.03 | 98.94 | 19.16 | 84.93 | 0.01 | 96.96 | 6.70 |
| 30-44 | 48.90 | 1.68 | 50.58 | 0.03 | 96.68 | 6.07 | 53.18 | 1.24 | 54.42 | 0.03 | 97.72 | 12.53 | 105.00 | 0.03 | 97.22 | 8.28 |
| 45-59 | 293.73 | 2.19 | 295.92 | 0.35 | 99.26 | 35.53 | 120.28 | 0.83 | 121.11 | 0.14 | 99.31 | 27.88 | 417.03 | 0.24 | 99.28 | 32.90 |
| 60-69 | 278.94 | 1.03 | 279.97 | 0.84 | 99.63 | 33.61 | 75.91 | 0.30 | 76.21 | 0.24 | 99.61 | 17.54 | 356.18 | 0.55 | 99.63 | 28.10 |
| 70-79 | 132.41 | 0.49 | 132.90 | 0.96 | 99.63 | 15.96 | 60.84 | 0.16 | 61.00 | 0.39 | 99.74 | 14.04 | 193.90 | 0.66 | 99.66 | 15.30 |
| ≥80 | 41.17 | 0.21 | 41.38 | 1.78 | 99.49 | 4.97 | 38.23 | 0.09 | 38.32 | 1.21 | 99.77 | 8.82 | 79.70 | 1.45 | 99.62 | 6.29 |
| Total | 825.40 | 7.56 | 832.96 | 0.07 | 99.09 | 100.00 | 430.79 | 3.63 | 434.42 | 0.04 | 99.16 | 100.00 | 1267.38 | 0.05 | 99.12 | 100.00 |
YLLs – years of life lost, YLDs – years lived with disability, NA – not applicable